Health Union Acknowledged by Inc. 5000 as One of the Fastest-Growing Companies in the U.S.
Inc. magazine announced that Health Union has been ranked No. 740 on the 37th annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. After steadily receiving awards and recognitions within the Philadelphia business community and life sciences industry over the past eight years, the Inc. 5000 represents Health Union’s first national recognition.
Survey Finds Migraine Patients Largely Unaware of Newly Available CGRP Medications
People living with migraine recently gained another significant tool to effectively manage their condition when the U.S. Food and Drug Administration approved the first treatment to target calcitonin-gene-related peptides (CGRP). However, only one-third of respondents of Migraine In America 2018, a national survey by Health Union, LLC of people impacted by the condition, are even aware of CGRP therapies.
Survey Finds ‘Scanxiety’ Is Common Challenge for Lung Cancer Patients
Living with lung cancer is accompanied by a considerable level of anxiety, with 86 percent of respondents reporting at least a little bit of anxiety on any given day. However, what is often referred to as “scanxiety” – the anxiety, fear and worry associated with scans, specifically before the results are revealed – can exacerbate those feelings. Of those who experience scanxiety, three-quarters reported either “more” or “a lot more” anxiety around the time of scans than at other times.
Health Union Announces Acceptance to Present at IASLC 19th World Conference on Lung Cancer
Health Union, LLC has been accepted for a poster presentation at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto. The poster, titled “Differentiating Characteristics of Patients Seeking a Second Opinion: A Survey on Non-Small Cell Lung Cancer Patients,” will be presented on Sept. 25.
